We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

13 hedge funds and large institutions have $1.02M invested in ENDRA Life Sciences in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding

Funds holding: 13 → 13 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

34% less capital invested

Capital invested by funds: $1.54M → $1.02M (-$523K)

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$71.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$53.7K
3
Osaic Holdings
Osaic Holdings
Arizona
+$17.9K
4
Citigroup
Citigroup
New York
+$8.94K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.94K

Top Sellers

Rank Fund Capital Flow
1
5L
55I LLC
Massachusetts
-$35K
2
BlackRock
BlackRock
New York
-$26.8K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$17.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$273K -$17.9K -2 -6%
Morgan Stanley
2
Morgan Stanley
New York
$199K – – –
NA
3
NewEdge Advisors
Louisiana
$153K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$132K +$53.7K +6 +60%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$80K +$8.94K +1 +11%
VF
6
Virtu Financial
New York
$65K +$71.5K +8 New
State Street
7
State Street
Massachusetts
$25K – – –
Osaic Holdings
8
Osaic Holdings
Arizona
$21K +$17.9K +2 +200%
TSS
9
Two Sigma Securities
New York
$18K – – –
Northern Trust
10
Northern Trust
Illinois
$15K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$9K – – –
UBS Group
12
UBS Group
Switzerland
$9K – – –
Citigroup
13
Citigroup
New York
$7K +$8.94K +1 New
IC
14
IEQ Capital
California
$4K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$4K – – –
Skandinaviska Enskilda Banken (SEB)
16
Skandinaviska Enskilda Banken (SEB)
Sweden
$1K – – –
WAM
17
Worth Asset Management
Texas
$1K – – –
5L
18
55I LLC
Massachusetts
– -$35K -3 Closed
BlackRock
19
BlackRock
New York
– -$26.8K -3 Closed

NDRA Hedge Fund Activity: Q2 2022 in Review

13 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2022, worth a combined $1.02M — down 34% from $1.54M a quarter earlier.

Fund positioning in NDRA was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $71.5K. The largest seller was 55I LLC, exiting entirely with an estimated $35K sold.

  • 13 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $1.02M of ENDRA Life Sciences stock for Q2 2022, down 34% quarter-over-quarter.
  • 2 funds opened new ENDRA Life Sciences positions in Q2 2022 and 2 closed out, a net change of 0 holders.
  • The largest ENDRA Life Sciences buyer in Q2 2022 was Virtu Financial, an estimated $71.5K added.
  • The largest ENDRA Life Sciences seller in Q2 2022 was 55I LLC, an estimated $35K sold.

Based on aggregated 13F filings for Q2 2022.